Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Clinical Laserthermia Systems B | CLSB | Nov 21, 2024 | 3.78 | +1.07 |
Cloetta | CLAB | Nov 21, 2024 | 25.52 | -0.08 |
Cloudberry Clean Energy ASA | CLOUDO | Nov 21, 2024 | 12.00 | 0.00 |
CodeMill | CDMIL | Nov 21, 2024 | 14.50 | +5.07 |
Coegin Pharma | COEGIN | Nov 21, 2024 | 4.01 | -1.72 |
CoinShares International Limited | CS | Nov 21, 2024 | 83.00 | +2.47 |
Combigene | COMBI | Nov 21, 2024 | 2.58 | +4.03 |
Combinedx | CX | Nov 21, 2024 | 31.20 | -2.50 |
Comintelli | COMINT | Nov 21, 2024 | 3.02 | +23.77 |
Compodium | COMPDM | Nov 21, 2024 | 5.70 | -3.39 |
Concejo B | CNCJOB | Nov 21, 2024 | 41.60 | +4.00 |
Condo Nordic Holding AB | CONDO | Nov 21, 2024 | 1.57 | -0.63 |
Consensus B | CAMB | Nov 21, 2024 | 12.35 | -0.40 |
Coor Service Management Holding | COOR | Nov 21, 2024 | 32.86 | -0.96 |
Corem Property Group A | COREA | Nov 21, 2024 | 6.70 | -1.47 |
Corem Property Group B | COREB | Nov 21, 2024 | 6.59 | -1.20 |
Corem Property Group D | CORED | Nov 21, 2024 | 247.50 | +1.02 |
Corem Property Group Pref | COREPREF | Nov 21, 2024 | 256.50 | -0.58 |
Corline Biomedical | CLBIO | Nov 21, 2024 | 6.60 | -4.62 |
Cortus Energy | CE | Nov 21, 2024 | 0.16 | +18.84 |
Creades A | CREDA | Nov 21, 2024 | 69.00 | +0.36 |
Creturner Group | CRET | Nov 21, 2024 | 0.16 | 0.00 |
Crown Energy | CRWN | Nov 21, 2024 | 0.70 | +23.89 |
Crunchfish | CFISH | Nov 21, 2024 | 1.40 | -5.91 |
CTEK | CTEK | Nov 21, 2024 | 16.36 | +2.76 |
CTT Systems | CTT | Nov 21, 2024 | 254.00 | +2.42 |
Curasight | CURAS | Nov 21, 2024 | 11.50 | -3.36 |
Cyber Security 1 | CYB1 | Nov 21, 2024 | 0.01 | -6.00 |
Cyclezyme AB | CYCLE | Nov 21, 2024 | 7.50 | +4.90 |
Cyxone | CYXO | Nov 21, 2024 | 0.03 | -29.76 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.